Novo Nordisk (NVO) slashed the price of its weight-loss blockbuster, Wegovy, by more than half on Wednesday amid a bitter rivalry with pharmaceutical compounder Hims & Hers Health (HIMS). Novo N… [+2935 chars]Read More
Novo Slashes Wegovy Price Undercutting Its Most Bitter Rival Investors Business Daily
